CN114113353B - Method for separating and detecting ethyl acetate and/or related impurities - Google Patents

Method for separating and detecting ethyl acetate and/or related impurities Download PDF

Info

Publication number
CN114113353B
CN114113353B CN202010896576.6A CN202010896576A CN114113353B CN 114113353 B CN114113353 B CN 114113353B CN 202010896576 A CN202010896576 A CN 202010896576A CN 114113353 B CN114113353 B CN 114113353B
Authority
CN
China
Prior art keywords
moxh
impurities
ethyl acetate
sm1f
sm1i
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010896576.6A
Other languages
Chinese (zh)
Other versions
CN114113353A (en
Inventor
张�荣
王俊入
周春燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Huabangshengkai Pharm Co ltd
Original Assignee
Chongqing Huabangshengkai Pharm Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Huabangshengkai Pharm Co ltd filed Critical Chongqing Huabangshengkai Pharm Co ltd
Priority to CN202010896576.6A priority Critical patent/CN114113353B/en
Publication of CN114113353A publication Critical patent/CN114113353A/en
Application granted granted Critical
Publication of CN114113353B publication Critical patent/CN114113353B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/30Control of physical parameters of the fluid carrier of temperature
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/32Control of physical parameters of the fluid carrier of pressure or speed
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8624Detection of slopes or peaks; baseline correction
    • G01N30/8631Peaks
    • G01N30/8634Peak quality criteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/32Control of physical parameters of the fluid carrier of pressure or speed
    • G01N2030/324Control of physical parameters of the fluid carrier of pressure or speed speed, flow rate
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8872Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample impurities

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Quality & Reliability (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to the technical field of medicine analysis, in particular to a method for analyzing ethyl gative carboxylate and related impurities by utilizing a high performance liquid chromatography. The chromatographic column adopted by the method uses phenyl bonded silica gel as a filler, adopts buffer salt solution and organic solvent for gradient elution, and has the flow rate of 0.9-1.1 ml/min and the column temperature of 23-27 ℃. The analysis method provided by the invention can well separate and accurately quantify the impurities MOXH-SM1f and MOXH-SM1i which have the structure similar to that of the ethyl acetate of the gative carboxylic acid within 37 minutes, can effectively separate the impurities from other 7 known impurities possibly existing in the ethyl acetate of the gative carboxylic acid, and provides the separation and measurement problems of the known impurities in the ethyl acetate of the gative carboxylic acid which are not solved by the prior art.

Description

Method for separating and detecting ethyl acetate and/or related impurities
Technical Field
The invention relates to the technical field of medicine analysis, in particular to a method for analyzing ethyl gative carboxylate and related impurities by utilizing a high performance liquid chromatography.
Background
Moxifloxacin is a chemical with a molecular formula of C 21 H 24 FN 3 O 4 Fluoroquinolones as antibacterial agents. The DNA topoisomerase inhibitor can be used for treating social acquired pneumonia, chronic bronchitis acute episode, acute sinusitis, etc. caused by Staphylococcus aureus, bacillus influenza, pneumococcus, etc. Belongs to a fourth-generation quinolone antibacterial drug, and is a new-generation antibiotic with broad antibacterial spectrum. The product has strong antibacterial activity against common respiratory tract bacteria such as Streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis and part of Staphylococcus aureus, and especially against Streptococcus pneumoniae. Clinically used for treating acute Dou Xianyan, acute episode of chronic bronchitis, community-acquired pneumonia, and skin infection and skin soft tissue infection without complications. The product has the characteristics of almost no photosensitive reaction, good tissue penetrating power, high concentration in lung tissues and good medicine for treating respiratory tract infection.
The ethyl acetate of the gatifloxacin is a key starting material of the moxifloxacin, and the quality control of the ethyl acetate of the gatifloxacin is beneficial to guaranteeing the quality of the moxifloxacin. According to the known impurity structural formula possibly contained in the finished product in the moxifloxacin hydrochloride EP10.3 pharmacopoeia quality standard, it is presumed that the following 2 impurities with a structure highly similar to that of ethyl acetate may exist in the raw material ethyl acetate:
Figure BDA0002658631620000011
at present, no related literature or data discloses a method for separating and detecting the two impurities.
Disclosure of Invention
In view of the above, it is an object of the present invention to provide a method for separating ethyl acetate and/or related impurities by an HPLC method, by which related substances can be efficiently separated and the separation time can be reduced.
In order to achieve the above purpose, the present invention provides the following solutions:
the method for separating the ethyl acetate of the gative carboxylic acid and/or related impurities by an HPLC method comprises the steps of taking phenyl bonding silica gel as a filler, and carrying out gradient elution by adopting a mobile phase A and a mobile phase B to separate the ethyl acetate of the gative carboxylic acid and/or related impurities; the related impurities are one or more of impurities MOXH-SM1a, MOXH-SM1b, MOXH-SM1e, MOXH-SM1m, MOXH-SM1g, MOXH-SM1h, MOXH-SM1j, MOXH-SM1f and MOXH-SM1i; the structural formula of the ethyl gative carboxylate and related impurities is specifically as follows:
Figure BDA0002658631620000021
Figure BDA0002658631620000031
the mobile phase A is buffer salt solution, and the mobile phase B is organic solvent;
further, the buffer salt solution is a mixed solution of potassium dihydrogen phosphate solution and triethylamine, and the pH value of the buffer salt solution is 2.8-3.2;
specifically, the pH of the buffer salt solution is 3.0;
specifically, the buffer salt solution uses phosphoric acid to adjust the pH;
further, the concentration of the potassium dihydrogen phosphate in the buffer salt solution is 0.005-0.05 mol/L, and the volume percentage of the triethylamine in the buffer salt solution is 0.05-5.0%.
Specifically, the mass concentration of the potassium dihydrogen phosphate in the buffer salt solution is 2.72g/L, and the volume percentage of triethylamine in the buffer salt solution is 0.3%;
further, the organic solvent is one or more of methanol, ethanol and acetonitrile;
specifically, the organic solvent is methanol;
further, the gradient elution is:
time/minute Mobile phase a/% Mobile phase B/%
0 38-42 58-62
3 40 60
20 30 70
23 20 80
29 20 80
30 40 60
37 40 60
Specifically, the gradient elution is:
time/minute Mobile phase a/% Mobile phase B/%
0 40 60
3 40 60
20 30 70
23 20 80
29 20 80
30 40 60
37 40 60
Further, the flow rate of the mobile phase in the method is 0.9-1.1 ml/min; in the method, the column temperature of the chromatographic column is 23-27 ℃;
specifically, the flow rate of the mobile phase in the method is 1.0ml/min; the column temperature of the chromatographic column in the method is 25 ℃.
It is a further object of the present invention to provide a method for identifying ethyl acetate and/or related impurities which is effective in identifying related substances and which reduces the identification time;
in order to achieve the above purpose, the present invention provides the following solutions:
the method for identifying the ethyl acetate and/or related impurities by using the HPLC method comprises the steps of utilizing the method in the first aim to separate the ethyl acetate and related impurities, and introducing the ethyl acetate and related impurities into a detector for detection, wherein the detection wavelength of the detector is 210-340 nm; the related impurity is the related impurity in purpose one; comparing the detected chromatogram with a known reference chromatogram, and identifying whether the detected object contains the ethyl acetate and/or related impurities;
specifically, the detector detects a wavelength of 250nm.
It is a further object of the present invention to provide a method for determining ethyl acetate of a gative carboxylic acid and/or impurities MOXH-SM1f and/or impurities MOXH-SM1i by HPLC; the method can effectively measure the content of related substances and control the measurement time;
in order to achieve the above purpose, the present invention provides the following solutions:
a method for measuring ethyl acetate and/or impurity MOXH-SM1f and/or impurity MOXH-SM1i by an HPLC method, wherein the ethyl acetate and/or impurity MOXH-SM1f and/or impurity MOXH-SM1i are separated by the method in the first aim, a chromatogram is obtained by detection in a detector with a detection wavelength of 250nm, and the content of the ethyl acetate and/or impurity MOXH-SM1f and/or impurity MOXH-SM1i is calculated according to the peak area;
specifically, the method comprises the following specific steps:
s1: reagent preparation
Dissolving a sample to be tested in a diluent to obtain a sample solution; dissolving a reference substance in a diluent to obtain a reference substance solution; placing the sample into a sample feeding disc with the temperature controlled between 2 and 8 ℃;
s2: separation
Separating the ethyl acetate and/or impurity MOXH-SM1f and/or impurity MOXH-SM1i using the method described in object one;
s3: authentication
Identifying whether the test object contains the ethyl acetate and/or the impurity MOXH-SM1f and/or the impurity MOXH-SM1i by using the method described in the second aim;
s4: content calculation
Measuring peak areas according to the obtained chromatograms, and calculating the contents of the ethyl acetate and/or the impurity MOXH-SM1f and/or the impurity MOXH-SM1i;
further, the diluent is water and acetonitrile;
specifically, the diluent is water and acetonitrile in a volume ratio of 1:1.
The invention has the beneficial effects that:
1. the analysis method provided by the invention can well separate and detect impurities MOXH-SM1f and MOXH-SM1i which have structures similar to that of the ethyl acetate of the gative carboxylic acid.
2. The separation degree between the main component of the analysis method and other known impurities possibly existing in the sample and impurities MOXH-SM1f and MOXH-SM1i is larger than 1.5, and the analysis method has the advantages of strong specificity, good durability, high sensitivity and good reproducibility.
3. The analysis method provided by the invention can well separate and accurately quantify the impurities MOXH-SM1f and MOXH-SM1i which have the structure similar to that of the ethyl acetate of the gative carboxylic acid within 37 minutes, can effectively separate the impurities from other 7 known impurities possibly existing in the ethyl acetate of the gative carboxylic acid, and provides the separation and measurement problems of the known impurities in the ethyl acetate of the gative carboxylic acid which are not solved by the prior art.
Drawings
Fig. 1: HPLC chromatogram of the mixed solution;
fig. 2: detection limit HPLC chromatogram;
fig. 3: durability 1HPLC chromatogram;
fig. 4: durability 2HPLC chromatogram;
fig. 5: durability 3HPLC chromatogram;
fig. 6: durability 4HPLC chromatogram;
fig. 7: durability 5HPLC chromatogram;
fig. 8: durability 6HPLC chromatogram;
fig. 9: durability 7HPLC chromatogram;
fig. 10: durability 8HPLC chromatogram.
Detailed Description
The examples are presented for better illustration of the invention, but the invention is not limited to the examples. Those skilled in the art will appreciate that various modifications and adaptations of the embodiments described above are possible in light of the above teachings and are intended to be within the scope of the invention.
Example 1
Taking a proper amount of the sample, precisely weighing, adding a diluent (water-acetonitrile, volume ratio is 1:1) for dissolving and quantitatively diluting to prepare a solution containing about 1mg in each 1ml, taking the solution as a sample solution, and immediately placing the sample solution into a sample injection tray with the temperature of 5 ℃ after preparation; precisely weighing 5.0ml, placing into a 50ml measuring flask, diluting to scale with diluent, shaking, precisely weighing 2.0ml, placing into a 100ml measuring flask, diluting to scale with diluent, shaking, and taking as control solution.
Chromatographic column (4.6mm.times.250 mm,5 μm) packed with phenyl-bonded silica gel; taking buffer salt (weighing 2.72g of monopotassium phosphate, adding 1000ml of water for dissolution, adding 3.0ml of triethylamine, adjusting pH to 3.0 with phosphoric acid) as a mobile phase A, taking methanol as a mobile phase B, performing linear gradient elution according to a table 1, and detecting the wavelength to be 250nm; the flow rate is 1.0ml per minute; the column temperature was 25 ℃.
TABLE 1 gradient elution table
Time [ (time ]Minute (min) Mobile phase a (%) Mobile phase B (%)
0 40 60
3 40 60
20 30 70
23 20 80
29 20 80
30 40 60
37 40 60
Accurately weighing a proper amount of a system applicability reference substance 1 (containing ethyl gative carboxylate MOXH-SM1, impurity MOXH-SM1i and impurity MOXH-SM1 f) of the ethyl gative carboxylate MOXH-SM1, accurately weighing, adding a diluent to dissolve and dilute the mixture to prepare a solution containing about 1mg of each 1ml, shaking the solution uniformly to serve as a system applicability solution, and immediately placing the solution into a sample injector with the temperature of 5 ℃ after preparation. Taking 10 μl, injecting into a liquid chromatograph, recording chromatogram, and sequentially making peaks according to impurities MOXH-SM1f, MOXH-SM1 and MOXH-SM1i, wherein the separation degree between the impurities MOXH-SM1f and the main component meets the requirement. Precisely measuring 10 μl of the sample solution and the control solution, respectively injecting into a liquid chromatograph, and recording the chromatograms. And calculating the contents of the two impurities according to a main component comparison method added with the correction factors.
Example 2
Specialization of
Impurities that may be present in ethyl acetate of gative SM 1: the impurities MOXH-SM1a, MOXH-SM1b, MOXH-SM1e, MOXH-SM1m, MOXH-SM1g, MOXH-SM1h, MOXH-SM1j, MOXH-SM1f and MOXH-SM1i are 9 in total, and the impurities MOXH-SM1f and MOXH-SM1i are studied in the method.
Taking 10 μl of each of blank solution, impurity positioning solution, other impurity mixed solution, sample solution and mixed solution, sequentially feeding, recording chromatogram, and measuring the results shown in tables 2 and 3 and shown in fig. 1.
TABLE 2HPLC chromatogram integration results for the mixed solution
Figure BDA0002658631620000081
TABLE 3 determination results of specificity test
Figure BDA0002658631620000082
Conclusion: the main components of the blank solution and the sample solution do not interfere with the impurity MOXH-SM 1f And impurity MOXH-SM 1i Other known impurities and impurities MOXH-SM which may be present in the main component and the sample 1f And impurity MOXH-SM 1i The separation degree between the two is more than 1.5, and the method specificity meets the requirements.
Example 3
Detection limit
And taking the detection limit solution to continuously sample for 3 times, and calculating the ratio (signal to noise ratio) of the peak height of the main peak to the noise. The test results are shown in tables 4 and 5 and in FIG. 2.
TABLE 4 detection limit HPLC chromatogram integration results
Figure BDA0002658631620000091
TABLE 5 detection limit measurement results
Figure BDA0002658631620000092
Conclusion: the detection limit concentration of the impurity MOXH-SM1f is 0.074 mug/ml, the concentration in the test sample is 0.007%, and the signal to noise ratio average value is 14.2; the detection limit concentration of the impurity MOXH-SM1i is 0.065 mug/ml, the concentration in the test sample is 0.007%, and the signal to noise ratio average value is 10.9; the detection limit concentration of the main component SM1 is 0.064 mug/ml, the concentration of the main component SM1 in a test sample is 0.006%, and the signal to noise ratio average value is 8.4, which all meet the requirement of the detection limit.
Example 4
Durability to chromatographic conditions
Taking mixed solution under the special item, respectively using normal chromatographic conditions, testing different column temperatures, column flow rates, mobile phase B-phase methanol initial proportion and mobile phase A-phase buffer salt pH value of a predetermined test, respectively testing after an instrument system is stable, recording the separation degree between peaks, and inspecting the relative retention time and normalized content change condition of known impurities. The test results are shown in tables 2, 6-14, FIG. 1, and FIGS. 3-10 below.
TABLE 6 durability 1HPLC chromatogram integration results
Figure BDA0002658631620000101
TABLE 7 durability 2HPLC chromatogram integration results
Figure BDA0002658631620000102
Figure BDA0002658631620000111
Table 8 durability 3HPLC chromatogram integration results
Figure BDA0002658631620000112
Table 9 durability 4HPLC chromatogram integration results
Figure BDA0002658631620000113
Figure BDA0002658631620000121
Table 10 durability 5HPLC chromatogram integration results
Figure BDA0002658631620000122
Table 11 durability 6HPLC chromatogram integration results
Figure BDA0002658631620000123
Figure BDA0002658631620000131
Table 12 durability 7HPLC chromatogram integration results
Figure BDA0002658631620000132
TABLE 13 durability 8HPLC chromatogram integration results
Figure BDA0002658631620000133
Figure BDA0002658631620000141
TABLE 14 determination of durability test for chromatographic condition change
Figure BDA0002658631620000142
Conclusion: when the chromatographic conditions slightly fluctuate, the separation degree between the impurity MOXH-SM1f and the main peak is more than 1.5, and the separation degree between the impurity MOXH-SM1i and the adjacent components is more than 1.4, so that the method has better durability.
Finally, it is noted that the above embodiments are only for illustrating the technical solution of the present invention and not for limiting the same, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications and equivalents may be made thereto without departing from the spirit and scope of the technical solution of the present invention, which is intended to be covered by the scope of the claims of the present invention.

Claims (6)

  1. The method for separating the ethyl acetate of the gative carboxylic acid and related impurities by an HPLC method is characterized in that a chromatographic column adopted by the method takes phenyl bonding silica gel as a filler, and a mobile phase A and a mobile phase B are adopted for gradient elution to separate the ethyl acetate of the gative carboxylic acid and related impurities; the related impurities are impurities MOXH-SM1f and impurities MOXH-SM1i; the structural formula of the ethyl gative carboxylate and related impurities is specifically as follows:
    Figure QLYQS_1
    the mobile phase A is buffer salt solution, and the mobile phase B is organic solvent; the buffer salt solution is a mixed solution of potassium dihydrogen phosphate solution and triethylamine, and the pH value of the buffer salt solution is 2.8-3.2; the mass concentration of the potassium dihydrogen phosphate in the buffer salt solution is 0.005-0.05 mol/L, and the volume percentage of the triethylamine in the buffer salt solution is 0.05-5.0%; the organic solvent is methanol; the gradient elution specifically comprises the following steps:
    time/minute Mobile phase a/% Mobile phase B/% 0 38-42 58-62 3 40 60 20 30 70 23 20 80 29 20 80 30 40 60 37 40 60
  2. 2. The method according to claim 1, wherein the flow rate of the mobile phase in the method is 0.9 to 1.1ml/min; the temperature of the chromatographic column in the method is 23-27 ℃.
  3. A method for identifying ethyl acetate and related impurities by an HPLC method, which is characterized in that the ethyl acetate and related impurities are separated by the method in claim 1 and are detected by a detector with the detection wavelength of 210-340 nm; the related impurity is the related impurity in claim 1; comparing the detected chromatogram with the chromatogram of the known reference substance, and identifying whether the detected substance contains the ethyl acetate and related impurities.
  4. A method for determining ethyl acetate and impurities MOXH-SM1f and MOXH-SM1i by an hplc method, characterized in that ethyl acetate and impurities MOXH-SM1f and MOXH-SM1i are separated by the method according to claim 1, detected in a detector with a detection wavelength of 250nm to obtain a chromatogram, and the contents of ethyl acetate and impurities MOXH-SM1f and impurities MOXH-SM1i are calculated according to peak areas.
  5. 5. The method according to claim 4, characterized in that the method comprises the following specific steps:
    s1: reagent preparation
    Dissolving a sample to be tested in a diluent to obtain a sample solution; dissolving a reference substance in a diluent to obtain a reference substance solution; placing the prepared reagent into a sample injection disc with the temperature controlled between 2 and 8 ℃;
    s2: separation
    Separating the ethyl acetate and impurities MOXH-SM1f and MOXH-SM1i using the process of claim 1;
    s3: authentication
    Identifying whether the test object contains the ethyl acetate and impurities MOXH-SM1f and MOXH-SM1i by the method of claim 3;
    s4: content calculation
    From the obtained chromatogram, the peak area was measured, and the contents of the ethyl acetate and the impurities MOXH-SM1f and MOXH-SM1i were calculated.
  6. 6. The method of claim 5, wherein the diluent is water or acetonitrile.
CN202010896576.6A 2020-08-31 2020-08-31 Method for separating and detecting ethyl acetate and/or related impurities Active CN114113353B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010896576.6A CN114113353B (en) 2020-08-31 2020-08-31 Method for separating and detecting ethyl acetate and/or related impurities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010896576.6A CN114113353B (en) 2020-08-31 2020-08-31 Method for separating and detecting ethyl acetate and/or related impurities

Publications (2)

Publication Number Publication Date
CN114113353A CN114113353A (en) 2022-03-01
CN114113353B true CN114113353B (en) 2023-05-02

Family

ID=80359959

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010896576.6A Active CN114113353B (en) 2020-08-31 2020-08-31 Method for separating and detecting ethyl acetate and/or related impurities

Country Status (1)

Country Link
CN (1) CN114113353B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018345A1 (en) * 2000-08-29 2002-03-07 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
CN110194767A (en) * 2019-06-06 2019-09-03 浙江国邦药业有限公司 A kind of preparation method of moxifloxacin hydrochloride and its intermediate
CN110470748A (en) * 2018-05-11 2019-11-19 四川科伦药物研究院有限公司 A kind of method of the high performance liquid chromatography detection moxifloxacin hydrochloride in relation to substance
CN110988167A (en) * 2019-12-06 2020-04-10 珠海润都制药股份有限公司 Method for detecting genotoxic impurities in gatifloxacin
CN111024831A (en) * 2018-10-09 2020-04-17 江苏正大丰海制药有限公司 Method for separating moxifloxacin hydrochloride and impurities thereof by high performance liquid chromatography

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018345A1 (en) * 2000-08-29 2002-03-07 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
CN110470748A (en) * 2018-05-11 2019-11-19 四川科伦药物研究院有限公司 A kind of method of the high performance liquid chromatography detection moxifloxacin hydrochloride in relation to substance
CN111024831A (en) * 2018-10-09 2020-04-17 江苏正大丰海制药有限公司 Method for separating moxifloxacin hydrochloride and impurities thereof by high performance liquid chromatography
CN110194767A (en) * 2019-06-06 2019-09-03 浙江国邦药业有限公司 A kind of preparation method of moxifloxacin hydrochloride and its intermediate
CN110988167A (en) * 2019-12-06 2020-04-10 珠海润都制药股份有限公司 Method for detecting genotoxic impurities in gatifloxacin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
M. Lalitha Devi 等.A Validated, Specific Stability-Indicating RP-LC Method for Moxifloxacin and Its Related Substances.Chromatographia.2009,第69卷993-999. *
王秀珍 等.加替沙星中主要杂质P-去甲加替沙星的分离、合成与结构鉴定.中国药科大学学报.2003,第34卷(第3期),272-273. *
高莹 等.高效液相色谱法测定盐酸莫西沙星原料药中的有关物质.中国抗生素杂志.2020,第45卷(第5期),455-462. *

Also Published As

Publication number Publication date
CN114113353A (en) 2022-03-01

Similar Documents

Publication Publication Date Title
WO2012075950A1 (en) Method for rapidly determining 16 species of inorganic anions and organic acids in tobacco simultaneously
CN111103372B (en) Method for detecting related substances of procaterol hydrochloride intermediate
CN102262135A (en) Method for detecting impurities in ambroxol hydrochloride injection and content determination method
CN115453012B (en) Reversed-phase HPLC method for simultaneously measuring multiple positional isomers in voathixetine hydrobromide
CN116953129A (en) Method for simultaneously determining twelve impurities in vonolamine fumarate by high performance liquid chromatography
CN109374781B (en) Method for detecting related substances in mezlocillin sodium and sulbactam sodium for injection
CN113588837B (en) Detection method of moxifloxacin hydrochloride related substance
CN114216987A (en) Method for analyzing cefixime tablets by high performance liquid chromatography
CN114113353B (en) Method for separating and detecting ethyl acetate and/or related impurities
CN111024831A (en) Method for separating moxifloxacin hydrochloride and impurities thereof by high performance liquid chromatography
CN114113355B (en) Method for separating and detecting ethyl acetate of gative carboxylate and/or related impurity by HPLC method
CN115248261B (en) HPLC analysis and detection method for related substances in tedizolid phosphate bulk drug
CN114689737B (en) Analysis method of S-o-chlorophenylglycine methyl tartrate related substances
CN115792047B (en) Method for detecting related substances of tedizolid phosphate intermediate
CN115248260A (en) HPLC analysis detection method for related substances in cisatracurium besilate bulk drug
CN114594168A (en) Method for detecting indobufen impurity
CN112067709A (en) Method for determining cefodizime sodium related substance for injection and application
CN115825292B (en) Method for detecting S-glycidol in glycidyl R-butyrate
CN114235972B (en) Method for determining content of linagliptin impurity RBP-1
CN108107120B (en) Method for measuring intermediate product 6, 6-dibromo penicillanic acid by adopting high performance liquid chromatography
CN112986468B (en) Analysis method for detecting ciprofloxacin chloride in ciprofloxacin hydrochloride tablet
CN117783344A (en) HPLC method for simultaneously determining linezolid and metabolites thereof
CN112394112B (en) Method for detecting content of hydroxychloroquine oxynitride impurities in hydroxychloroquine sulfate
CN118067860A (en) Detection method of related substances in epalrestat tablet
CN108802211B (en) Liquid phase detection method for related substances in cefquinome sulfate breast injectant

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant